BIO-RAD LABORATORIES, INC. Deferred Income Tax Expense (Benefit)
BIO-RAD LABORATORIES, INC. (BIO.B) reported Deferred Income Tax Expense (Benefit) of $170.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-13
- BIO-RAD LABORATORIES, INC. deferred income tax expense (benefit) for fiscal 2025 was $170.50M.
- BIO-RAD LABORATORIES, INC. deferred income tax expense (benefit) for fiscal 2024 was -$626.80M.
- BIO-RAD LABORATORIES, INC. deferred income tax expense (benefit) for fiscal 2023 was -$322.60M.
- BIO-RAD LABORATORIES, INC. deferred income tax expense (benefit) for fiscal 2022 was -$1.24B, a 214.44% decline from fiscal 2021.
| Period end | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $170.50M 10-K · filed 2026-02-13 | |
| 2024-12-31 | -$626.80M 10-K · filed 2026-02-13 | |
| 2023-12-31 | -$322.60M 10-K · filed 2026-02-13 | |
| 2022-12-31 | -$1.24B 10-K · filed 2025-02-14 | |
| 2021-12-31 | $1.08B 10-K · filed 2024-02-16 | $1.08B 10-K · filed 2022-02-11 |
| 2020-12-31 | $981.40M 10-K · filed 2023-02-17 | $979.00M 10-K · filed 2021-02-16 |
| 2019-12-31 | $450.20M 10-K · filed 2022-02-11 | |
| 2018-12-31 | $120.90M 10-K · filed 2021-02-16 | |
| 2017-12-31 | -$84.80M 10-K · filed 2020-03-02 | |
| 2016-12-31 | -$51.20M 10-K · filed 2019-04-01 | |
| 2015-12-31 | -$3.70M 10-K · filed 2018-04-16 | -$6.10M 10-K · filed 2016-02-29 |
| 2014-12-31 | -$6.00M 10-K · filed 2017-03-01 | |
| 2013-12-31 | -$4.70M 10-K · filed 2016-02-29 | |
| 2012-12-31 | -$10.30M 10-K · filed 2015-03-02 | |
| 2011-12-31 | -$2.00M 10-K · filed 2014-03-18 | |
| 2010-12-31 | -$4.10M 10-K · filed 2013-03-18 | |
| 2009-12-31 | -$11.70M 10-K · filed 2012-02-29 |